Effect of Milnacipran in Chronic Neuropathic Low Back Pain
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Low back pain is a public health problem affecting between 70-85% of adults at some time in
their life. This study is being done to study the safety and effectiveness of the drug
Milnacipran in treating chronic low back pain.
Phase:
Phase 2
Details
Lead Sponsor:
Northwestern University
Collaborators:
Best Practice Forest Laboratories Rehabilitation Institute of Chicago Shirley Ryan AbilityLab